Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FCHSD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
API5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZHX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF282 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMIM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM234B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAMPT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLJ45482 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
GADD45B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MICU3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SF3B3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC35E3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DGKH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on